A New Method for Studying the Kinetics of the Release of Poorly Soluble API from Solid Oral Dosage Forms on the Example of Quertin®





quercetin, Biopharmaceutical Classification System, quantitative determination, method development, bioequivalence, bioavailability, solubility, dissolution test


In this paper, it is proposed to consider a new method developed for studying the kinetics of release of substances that are poorly soluble in aqueous media on the example of quercetin. The study object was the drug containing plant bioactive components – Quertin® chewable tablets, 40 mg, 3 blisters, 10 pcs – produced by PJSC SIC “Borshchahivskiy CPP”. An Agilent 1290 Infinity II LC System liquid chromatograph with an Agilent 6530 mass selective detector (Agilent Technologies) was used for the analysis. Solubility profiles were studied in accordance with the requirements of the Biopharmaceutical Classification System (BCS). The solubility limit of the substance in the media studied has been determined. A method for the quantitative determination of quercetin in test media in the range of specified concentrations with high sensitivity and selectivity has been developed. The dissolution of Quertin® chewable tablets in 3 different aqueous dissolution media with pH 1.2, pH 4.5 and pH 6.8 was studied, the dissolution profiles were compared, and the f2 factor was calculated. This factor is a criterion for evaluating the study by comparing dissolution kinetics with in vivo results. The results obtained indicate that the approach proposed to studying the kinetics of the release of substances that are sparingly soluble in aqueous solutions allows us to correctly assess the release of such substances in accordance with the requirements of the BCS. The method developed has been validated.

Supporting Agency

  • The work is a part of the research of the National University of Pharmacy on the topic “Organic synthesis and analysis of biologically active compounds, drug development based on synthetic substances” (the state registration No. 01144000943; the research period of 2019 – 2024).


Download data is not yet available.


  1. Guideline 42–7.4:2022. Likarski zasoby. Doslidzhennia biodostupnosti ta bioekvivalentnosti (Drugs. Bioavailability and bioequivalence studies, in Ukrainian). Ministry of Health of Ukraine. Кyiv, 2020.
  2. Pearce, G. A.; McLachlan, A. J.; Ramzan, I. Bioequivalence: How, Why, and What Does it Really Mean? Journal of Pharmacy Practice and Research 2004, 34 (3), 195-200. https://doi.org/10.1002/jppr2004343195.
  3. Derzhavna farmakopeia Ukrainy: v 3 tomakh, 2 vydannia [The State Pharmacopoeia of Ukraine: in 3 volumes, 2nd ed., in Ukrainian]; State Enterprise “Ukrainian Scientific Pharmacopoeial Center for Quality of Medicines”: Kharkiv, 2015; Vol. 1.
  4. Talevi, A.; Bellera, C. L. Biopharmaceutics Drug Disposition Classification System. In The ADME Encyclopedia: A Comprehensive Guide on Biopharmacy and Pharmacokinetics, Talevi, A., Ed. Springer International Publishing: Cham, 2022; pp 185-189. https://doi.org/10.1007/978-3-030-84860-6_70.
  5. Khanina, N.; Georgiyants, V.; Khanin, V. Development of a method for the quantitative determination of the solubility limits of poorly soluble in water substances on the example of quercetin. ScienceRise: Pharmaceutical Science 2023, 3, 58-66. https://doi.org/10.15587/2519-4852.2023.283293.
  6. Khanina, N.; Georgiyants, V.; Khanin, V. Development of a new solution for determining the solubility limit of quercetin and other poorly soluble substances in aqueous solutions using the method for determining total organic carbon. ScienceRise: Pharmaceutical Science 2023, 4, 54-62. https://doi.org/10.15587/2519-4852.2023.286639.
  7. Aguirre, L.; Arias, N.; Macarulla, M. T.; Gracia, A.; Portillo, M. P. Beneficial Effects of Quercetin on Obesity and The Open Nutraceuticals Journal 2011, 4, 189-198. http://dx.doi.org/10.2174/1876396001104010189.
  8. Cermak, R.; Landgraf, S.; Wolffram, S. The Bioavailability of Quercetin in Pigs Depends on the Glycoside Moiety and on Dietary Factors. The Journal of Nutrition 2003, 133 (9), 2802-2807. https://doi.org/10.1093/jn/133.9.2802.
  9. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. Validation of Analytical Procedures: Text and Methodology Q2(R1). https://database.ich.org/sites/default/files/Q2%28R1%29%20Guideline.pdf (accessed Aug 17, 2023).
  10. El-Khateeb, E.; Burkhill, S.; Murby, S.; Amirat, H.; Rostami-Hodjegan, A.; Ahmad, A. Physiological-based pharmacokinetic modeling trends in pharmaceutical drug development over the last 20-years; in-depth analysis of applications, organizations, and platforms. Biopharmaceutics & Drug Disposition 2021, 42 (4), 107-117. https://doi.org/10.1002/bdd.2257.
  11. Draft Guidance for Industry on Bioanalytical Method Validation. https://www.regulations.gov/document/FDA-2013-D-1020-0002 (accessed Aug 29, 2023).
  12. Guidance Document. Bioavailability Studies Submitted in NDAs or INDs – General Considerations. April 2022. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/bioavailability-studies-submitted-ndas-or-inds-general-considerations (accessed Sep 14, 2023).
  13. Gao, Y.; Gesenberg, C.; Zheng, W. Chapter 17 - Oral Formulations for Preclinical Studies: Principle, Design, and Development Considerations. In Developing Solid Oral Dosage Forms (Second Edition), Qiu, Y.; Chen, Y.; Zhang, G. G. Z.; Yu, L.; Mantri, R. V., Eds. Academic Press: Boston, 2017; pp 455-495. https://doi.org/10.1016/B978-0-12-802447-8.00017-0.
  14. He, J.; Feng, Y.; Ouyang, H.-z.; Yu, B.; Chang, Y.-x.; Pan, G.-x.; Dong, G.-y.; Wang, T.; Gao, X.-m. A sensitive LC–MS/MS method for simultaneous determination of six flavonoids in rat plasma: Application to a pharmacokinetic study of total flavonoids from mulberry leaves. Pharm. Biomed. Anal. 2013, 84, 189-195. https://doi.org/10.1016/j.jpba.2013.06.019.
  15. Li, J.; Wang, Z.-W.; Zhang, L.; Liu, X.; Chen, X.-H.; Bi, K.-S. HPLC analysis and pharmacokinetic study of quercitrin and isoquercitrin in rat plasma after administration of Hypericum japonicum thunb. extract. Chromatogr. 2008, 22 (4), 374-378. https://doi.org/10.1002/bmc.942.
  16. Lu, L.; Qian, D.; Yang, J.; Jiang, S.; Guo, J.; Shang, E.-x.; Duan, J.-a. Identification of isoquercitrin metabolites produced by human intestinal bacteria using UPLC-Q-TOF/MS. Chromatogr. 2013, 27 (4), 509-514. https://doi.org/10.1002/bmc.2820.
  17. Kawabata, K.; Mukai, R.; Ishisaka, A. Quercetin and related polyphenols: new insights and implications for their bioactivity and bioavailability. Food & Function 2015, 6 (5), 1399-1417. https://doi.org/10.1039/C4FO01178C.
  18. Quercetin. https://pubchem.ncbi.nlm.nih.gov/compound/Quercetin (accessed Sep 7, 2023).




How to Cite

Khanina, N. V.; Georgiyants, V. A.; Khanin, V. A.; Zupanetz, I. A. A New Method for Studying the Kinetics of the Release of Poorly Soluble API from Solid Oral Dosage Forms on the Example of Quertin®. J. Org. Pharm. Chem. 2023, 21, 50-60.



Original Researches